Project #21: Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales

Authors

Megan Hardy, Henry Ford Health
Rachel Kenney, Henry Ford HealthFollow
Amy Beaulac, Henry Ford HealthFollow
Tricia Stein, Henry Ford HealthFollow
Erin Eriksson, Henry Ford HealthFollow
Vivek Kak, Henry Ford HealthFollow
Asgar Boxwalla, Henry Ford HealthFollow
Shaina Vincent, Henry Ford Health
Nasir Husain, Henry Ford HealthFollow
Anita B. Shallal, Henry Ford HealthFollow
Robert Tibbetts, Henry Ford HealthFollow
Kathy Callahan, Henry Ford HealthFollow
Allison Weinmann, Henry Ford HealthFollow
Geehan Suleyman, Henry Ford HealthFollow
Michael Veve, Henry Ford HealthFollow

Files

Description

Aim: To implement and evaluate the impact of a stewardship intervention on the antibiotic treatment of severe infections due to low- and no-risk Enterobacterales. The historical standard of care for the treatment of infections due to these organisms was broad-spectrum intravenous antibiotic therapy with cefepime or a carbapenem such as ertapenem or meropenem. More recent evidence suggests that ceftriaxone, a narrower spectrum antibiotic, is an appropriate choice. Therefore, we aimed to change prescribing practices across Henry Ford Health hospitals to use narrower spectrum therapy to achieve the same patient outcomes.

Publication Date

3-12-2024

Publisher

Henry Ford Health

City

Detroit, Michigan

Keywords

Quality Expo, posters, poster competition

Recommended Citation

Hardy, Megan; Kenney, Rachel; Beaulac, Amy; Stein, Tricia; Eriksson, Erin; Kak, Vivek; Boxwalla, Asgar; Vincent, Shaina; Husain, Nasir; Shallal, Anita B.; Tibbetts, Robert; Callahan, Kathy; Weinmann, Allison; Suleyman, Geehan; and Veve, Michael, "Project #21: Leveraging stewardship to promote ceftriaxone use in severe infections with low- and no-risk AmpC Enterobacterales" (2024). Quality Expo 2024. 29.
https://scholarlycommons.henryford.com/qualityexpo2024/29